A-ha Frontman Morten Harket Reveals Secret 30-Year Battle With Parkinson's
A-ha frontman Morten Harket reveals he likely lived with Parkinson's disease for 30 years before a 2022 diagnosis, discussing deep brain treatments and his musical future.

Morten Harket, the 67-year-old frontman of the iconic synth-pop band a-ha, has revealed that medical professionals estimate he lived with Parkinson's disease for some three decades before receiving a formal diagnosis in 2022. Best known globally for the enduring 1985 smash hit "Take On Me", the Norwegian singer opened up about his decades-long hidden struggle, the complex medical treatments he undergoes, the noticeable changes to his singing voice, and the unsettling sensation of losing control over his emotional responses.
Decades of Hidden Symptoms and Unexpected Diagnosis
Although Harket only made his diagnosis public via the band's official website in June 2025, doctors believe the neurodegenerative condition had been present for roughly thirty years. He explained that his brain initially managed to compensate for the early underlying signs, allowing him to function normally until the degeneration reached a critical threshold. The turning point occurred during a mundane daily routine when holding a toothbrush suddenly felt awkward and clumsy. A primary care physician immediately suspected Parkinson's, and a subsequent PET scan confirmed the diagnosis.
Reflecting on the psychological toll of the condition, Harket admitted that one of the hardest aspects is feeling estranged from oneself. "Sometimes I suddenly cry and can't stop, or I laugh, but it's not me," he shared. "These emotions don't feel like mine. It's a hard thing, feeling like you are losing who you are." Beyond mood fluctuations, the progressive disorder has caused significant weight loss, a loss of taste and smell, and a severe six-month bout of insomnia. Yet, he maintains a pragmatic perspective, drawing inspiration from his 94-year-old father's philosophy on physical decline: "I use what works."
Advanced Medical Treatments and Creative Uncertainty
As symptoms intensified in the summer of 2024, Harket traveled to the Mayo Clinic in Florida to undergo deep brain stimulation therapy. Surgeons implanted electrodes into his brain designed to transmit electrical impulses and regulate abnormal neural activity. While the procedure alleviated certain symptoms, finding the correct therapeutic balance remains a delicate daily challenge.
"With too little stimulation, my train of thought or speech can fade away. With too much, I can go completely wild, with involuntary movements, spasms, and contractions," Harket explained.
In addition to deep brain stimulation, he relies on a continuous infusion pump delivering prodopa, a dopamine-mimicking medication, and spends considerable energy trying to stabilize his physical system. These neurological hurdles have inevitably impacted his musical career. Discussing his vocal changes with the band's biographer, Jan Omdal, Harket acknowledged that his future in music remains uncertain. He noted that his voice has altered and that he currently lacks the desire to sing, leaving open the question of whether he will ever perform on stage again.
Formed in 1982 alongside bandmates Paul Waaktaar-Savoy and Magne Furuholmen, a-ha captured international superstardom with their debut album Hunting High and Low, before continuing a decades-long musical journey with acclaimed releases such as Memorial Beach, Lifelines, Cast in Steel, and the hit Summer Moved On. Despite the profound uncertainties ahead, Harket remains grounded, refusing to harbor bitterness as he navigates this new chapter of his life.





